Sildenafil: 10-year application in clinical andrology in China.
- Author:
Xue-Jun SHANG
1
;
Yu-Feng HUANG
Author Information
1. Department of Andrology, Nanjing General Hospital of Nanjing Military Region, Nanjing, Jiangsu 210002, China. shangxj@androl.cn
- Publication Type:Journal Article
- MeSH:
China;
Erectile Dysfunction;
drug therapy;
Humans;
Male;
Piperazines;
therapeutic use;
Premature Ejaculation;
drug therapy;
Purines;
therapeutic use;
Sildenafil Citrate;
Sulfones;
therapeutic use
- From:
National Journal of Andrology
2012;18(8):742-746
- CountryChina
- Language:Chinese
-
Abstract:
Sildenafil (Viagra) citrate has been well accepted by physicians and patients for its reliable efficacy and safety in the treatment of erectile dysfunction (ED) ever since its introduction into clinical andrology in China 10 years ago. It has been proved effective for various ED subgroups, regardless of causes, severity and age. Recent studies show that sildenafil also benefits patients with premature ejaculation, either used alone or in combination with other therapies.
